Key PointsCEO Leon Moulder acquired 60,000 shares for a total value of approximately $1.01 million on May 18, 2026.This transaction represents 13.04% of his aggregate holdings prior to the transaction.The purchase is consistent with a pattern of net buying, and reflects ongoing accumulation capacity, as holdings have expanded substantially over the past year.10 stocks we like better than Zenas BioPharma › Leon O. Molder Jr., Chief Executive Offi…